Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orange Capital Further Raises Stake in This Company and Appoints Two Directors

In a new filing with the Securities and Exchange Commission, Daniel LewisOrange Capital reported raising their stake in Bellatrix Exploration Ltd (NYSE:BXE). Orange currently owns some 27.45 million shares of the company, up from 25.76 million shares held earlier. Following the increase, Orange holds an activist stake that amasses 14.3% of Bellatrix’s common stock, versus 13.5% disclosed in an earlier filing.

Daniel Lewis - Orange Capital

Since Orange holds an activist stake in Bellatrix Exploration Ltd (NYSE:BXE), the fund has recently entered into an agreement with the company regarding the board of directors composition. Under the terms of the agreement, the company will nominate Danile Lewis and Steven J. Pully to be elected to the board at the 2015 meeting of shareholders and will take all the steps necessary to appoint them to the board, effective January 1.

The recent increase of the position in Bellatrix Exploration Ltd (NYSE:BXE) comes only a couple of weeks after Orange raised the stake from 23.8 million shares, which represented 12.4% of the company. The fund has been bullish on the stock since adding it to its equity portfolio during the third quarter of 2014. In the latest round of 13F filings, Bellatrix was already the largest long equity position in terms of value, amassing almost 8% of Orange’s $1.40 billion equity portfolio. In October, the fund further raised its stake to 21.16 million shares from 17.49 million shares that it disclosed in its latest 13F filing.

Meanwhile, the stock of Bellatrix Exploration Ltd (NYSE:BXE) fell by more than 44% since the end of September. The decline came on the back of a major slump in oil stocks, but the small-cap Canada-based oil & gas exploration and production company has made some moves that will strenghten the company in the long run. At the beginning of December, the company announced that it had acquired $118 million worth of assets within its Aldre Flats region that will add around 2,200 barrels of oil equivalent per day to its production.

Orange Capital is the shareholder with the largest stake in Bellatrix Exploration Ltd (NYSE:BXE) among institutional investors. In addition, David Dreman‘s Dreman Value Management disclosed holding 864,500 shares in its latest 13F filing, followed by Mark Rachesky‘s MHR Fund Management with 530,000 shares.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!